4D MOLECULAR THERAPEUTICS INC. - COMMON STOCK
4.3100
02-July-25 13:45:00
15 minutes delayed
Stocks
+0.1600
+3.86%
Today's range
4.1500 - 4.4000
ISIN
N/A
Source
NASDAQ
-
02 Jul 2025 13:05:00 By Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
28 May 2025 05:00:31 By Nasdaq GlobeNewswire
-
4DMT Announces New Employment Inducement Grants
16 May 2025 13:05:00 By Nasdaq GlobeNewswire
-
08 May 2025 13:05:03 By Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
05 May 2025 05:00:21 By Nasdaq GlobeNewswire
-
4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME
01 May 2025 05:00:46 By Nasdaq GlobeNewswire
-
4DMT Announces New Employment Inducement Grants
11 Apr 2025 13:05:00 By Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
27 Mar 2025 05:00:10 By Nasdaq GlobeNewswire
-
10 Mar 2025 05:00:00 By Nasdaq GlobeNewswire
-
28 Feb 2025 13:05:00 By Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
19 Feb 2025 05:00:36 By Nasdaq GlobeNewswire
-
08 Feb 2025 11:30:24 By Nasdaq GlobeNewswire
-
29 Jan 2025 05:00:00 By Nasdaq GlobeNewswire
-
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway
10 Jan 2025 05:00:00 By Nasdaq GlobeNewswire
-
10 Jan 2025 05:00:00 By Nasdaq GlobeNewswire
-
16 Dec 2024 05:00:00 By Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV
14 Nov 2024 05:00:00 By Nasdaq GlobeNewswire
-
13 Nov 2024 13:05:00 By Nasdaq GlobeNewswire
-
4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference
23 Sep 2024 05:00:00 By Nasdaq GlobeNewswire
-
18 Sep 2024 13:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >